NASDAQ:DRMA | Profit Breakdown | Dermata Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$3.01M-$2.97M
2026-03-31-$1.93M-$1.85M
2025-12-31-$1.9M-$1.86M
2025-09-30-$1.76M-$1.69M
2025-06-30-$1.77M-$1.7M
2025-03-31-$2.34M-$2.3M
2024-12-31-$3.2M-$3.15M
2024-09-30-$3.23M-$3.17M
2024-06-30-$2.88M-$2.83M
2024-03-31-$3.2M-$3.13M
2023-12-31-$2.22M-$2.13M
2023-09-30-$1.81M-$1.72M
2023-06-30-$1.73M-$1.7M
2023-03-31-$2.28M-$2.24M
2022-12-31-$1.71M-$1.67M
2022-09-30-$2.45M-$2.42M
2022-06-30-$2.73M-$2.73M
2022-03-31-$2.79M-$2.79M
2021-12-31-$2.55M-$2.55M
2021-09-30-$1.71M-$1.71M
2021-06-30-$1.33M-$1.33M
2021-03-31-$2.26M-$2.3M
2020-12-31-$491,427.00-$396,313.00
2020-09-30-$540,062.00-$597,395.00
2020-06-30-$792,786.00-$821,649.00
2020-03-31-$1.42M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$7.77M-$7.56M
2024-12-31-$12.51M-$12.29M
2023-12-31-$8.04M-$7.79M
2022-12-31-$9.67M-$9.61M
2021-12-31-$7.86M-$7.9M
2020-12-31-$3.17M-$3.24M